FluoTag-Q anti-S1-SARS-CoV-2

FluoTag-Q anti-S1-SARS-CoV-2

This anti-S1 Sars-CoV-2 nanobody was developed by the team of Alejandro Rojas-Fernandez at the Institute of Medicine from the Universidad Austral de Chile. We acquired the exclusive license to produce this nanobody and make it available or research and development purposes. The FluoTag-Q anti-S1 SARS-CoV-2 is based on the W25 clone, which has a sub-nanomolar affinity for the SARS-CoV-2 S1 protein receptor binding domain (RBD) and can neutralize infections as it efficiently competes with ACE-2 receptor binding.

Datasheet: Download PDF

Specificity: RBD of S1 protein from SARS-CoV-2
Produced in: E. coli
Concentration: 5 µM protein, 5 µM fluorophore
Recommended dilution for IF/ ICC: 1:500
Available conjugates: Abberior® Star RED, Abberior® Star 580, Abberior® Star 635P, Alexa Fluor® 647, Atto 488, Atto 542, Atto 565, Atto 647N, Sulfo-Cyanin 3, Sulfo-Cyanin 5, DBCO and biotin. For other fluorophores or conjugates please contact us.

Relevant Documents

Product List

Product name Coupled to Volume Net price (€) Catalog Number Order at Customized
FluoTag-Q anti-S1-SARS-CoV-2 see above 20µL / 200 µL see webshop N3501

WEBSHOP

Contact Us

This information is provided without liability and may be subject to change without prior notification.

References

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity Nanobody
doi: https://doi.org/10.1101/2020.06.09.137935